Go Tanigawa

610 total citations
39 papers, 468 citations indexed

About

Go Tanigawa is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Go Tanigawa has authored 39 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 9 papers in Oncology. Recurrent topics in Go Tanigawa's work include Urinary and Genital Oncology Studies (11 papers), Renal cell carcinoma treatment (9 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Go Tanigawa is often cited by papers focused on Urinary and Genital Oncology Studies (11 papers), Renal cell carcinoma treatment (9 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Go Tanigawa collaborates with scholars based in Japan, Greece and United States. Go Tanigawa's co-authors include Kazutoshi Fujita, Seiji Yamaguchi, Norio Nonomura, Motohide Uemura, Masahiro Hosomi, Atsunari Kawashima, Takuji Hayashi, Ryoichi Imamura, Akira Nagahara and Takeshi Ujike and has published in prestigious journals such as The Journal of Urology, European Journal of Cancer and Oncotarget.

In The Last Decade

Go Tanigawa

33 papers receiving 464 citations

Peers

Go Tanigawa
Glen W. Barrisford United States
Andres Correa United States
Wassim M. Bazzi United States
Stephan Buse Germany
Sudhir Isharwal United States
Nico C. Grossmann Switzerland
Glen W. Barrisford United States
Go Tanigawa
Citations per year, relative to Go Tanigawa Go Tanigawa (= 1×) peers Glen W. Barrisford

Countries citing papers authored by Go Tanigawa

Since Specialization
Citations

This map shows the geographic impact of Go Tanigawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Go Tanigawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Go Tanigawa more than expected).

Fields of papers citing papers by Go Tanigawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Go Tanigawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Go Tanigawa. The network helps show where Go Tanigawa may publish in the future.

Co-authorship network of co-authors of Go Tanigawa

This figure shows the co-authorship network connecting the top 25 collaborators of Go Tanigawa. A scholar is included among the top collaborators of Go Tanigawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Go Tanigawa. Go Tanigawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukuhara, Shinichiro, Takahiro Imanaka, Kentaro Takezawa, et al.. (2024). Association between serum testosterone changes and parameters of the metabolic syndrome. Endocrine Journal. 71(12). 1125–1133. 1 indexed citations
2.
Yoshinaga, Mitsuhiro, Norihiko Kawamura, Masahiro Nakagawa, et al.. (2019). [A Case of Pericardial Effusion Induced by Nivolumab for Metastatic Renal Cell Carcinoma].. PubMed. 65(8). 329–332. 1 indexed citations
3.
Kawashima, Atsunari, Motohide Uemura, Taigo Kato, et al.. (2018). Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma. International Journal of Clinical Oncology. 24(1). 78–86. 2 indexed citations
4.
Takezawa, Kentaro, Masataka Kawamura, Go Tanigawa, et al.. (2017). Robot-Assisted Laparoscopic Prostatectomy in a Prostate Cancer Patient Undergoing Continuous Ambulatory Peritoneal Dialysis. Journal of Endourology Case Reports. 3(1). 42–44.
5.
Fujita, Kazutoshi, Teruo Inamoto, Yu Ishizuya, et al.. (2017). Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis. BMC Urology. 17(1). 110–110. 20 indexed citations
6.
Takao, Tetsuya, Masataka Kawamura, Kosuke Nakano, et al.. (2017). Case of pazopanib-induced thyrotoxicosis in a patient with metastatic renal cell carcinoma. International Cancer Conference Journal. 6(3). 118–120.
7.
Yamamichi, Gaku, et al.. (2016). [A Case of Steroid Sulfatase Deficiency Complicated by Bilateral Undescended Testis].. PubMed. 62(11). 595–597. 1 indexed citations
8.
Takao, Tetsuya, Gaku Yamamichi, Kosuke Nakano, et al.. (2016). The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. International Journal of Clinical Oncology. 22(1). 153–158. 19 indexed citations
9.
Takao, Tetsuya, Gaku Yamamichi, Masataka Kawamura, et al.. (2016). [Two Cases of Penile Fracture Diagnosed by Magnetic Resonance Imaging].. PubMed. 62(9). 501–503.
10.
Tsutahara, Koichi, et al.. (2016). Clinical analysis of severe psychiatric disorders in patients with testicular cancer: A single‐center experience. International Journal of Urology. 23(7). 626–627. 1 indexed citations
11.
Fujita, Kazutoshi, Takeshi Ujike, Akira Nagahara, et al.. (2015). Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy. International Journal of Urology. 22(5). 463–467. 7 indexed citations
12.
Matsuzaki, Kyosuke, Ryoichi Imamura, Masahiro Nakagawa, et al.. (2015). A rare case of spontaneous necrosis of primary renal cell carcinoma. Canadian Urological Association Journal. 9(1-2). 33–33. 1 indexed citations
13.
Fujita, Kazutoshi, Motohide Uemura, Yoshiyuki Yamamoto, et al.. (2014). Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. International Journal of Clinical Oncology. 20(1). 156–163. 22 indexed citations
14.
Fujita, Kazutoshi, Ryoichi Imamura, Go Tanigawa, et al.. (2012). Low serum neutrophil count predicts a positive prostate biopsy. Prostate Cancer and Prostatic Diseases. 15(4). 386–390. 32 indexed citations
15.
Kawashima, Atsunari, Akira Tsujimura, Hitoshi Takayama, et al.. (2012). Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy. International Journal of Urology. 19(12). 1050–1057. 21 indexed citations
16.
Kawashima, Atsunari, Akira Tsujimura, Hitoshi Takayama, et al.. (2012). Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma. Medical Oncology. 29(5). 3298–3305. 23 indexed citations
17.
Yamamoto, Yoshiyuki, Kazutoshi Fujita, Shigeaki Nakazawa, et al.. (2012). Clinical characteristics and risk factors for septic shock in patients receiving emergency drainage for acute pyelonephritis with upper urinary tract calculi. BMC Urology. 12(1). 4–4. 46 indexed citations
18.
Fujita, Kazutoshi, Go Tanigawa, Ryoichi Imamura, et al.. (2012). Preoperative serum sodium is associated with cancer‐specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. International Journal of Urology. 20(6). 594–601. 10 indexed citations
19.
Kawashima, Atsunari, Yasutomo Nakai, Masashi Nakayama, et al.. (2011). The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study. World Journal of Urology. 30(5). 701–706. 23 indexed citations
20.
Kawashima, Atsunari, Hitoshi Takayama, Yasuyuki Arai, et al.. (2011). One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patients. European Journal of Cancer. 47(10). 1521–1526. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026